Drug Type Small molecule drug |
Synonyms IPG 001, IPG 1094, IPG-001 + [3] |
Target |
Mechanism MIF inhibitors(Macrophage migration inhibitory factor inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Advanced Malignant Solid Neoplasm | Phase 2 | CN | 20 Feb 2024 | |
Inflammatory Bowel Diseases | Phase 1 | CN | 30 Jan 2022 | |
Psoriasis | IND Approval | CN | 17 Dec 2021 | |
Multiple Sclerosis | IND Approval | CN | 08 Dec 2021 | |
Systemic Lupus Erythematosus | IND Approval | CN | 07 Dec 2021 | |
Multiple Myeloma | IND Approval | CN | 01 Dec 2021 |